Skip to main content
. 2014 Feb 28;9(2):e89895. doi: 10.1371/journal.pone.0089895

Figure 2. Local administration of 2.17-mAlb inhibited melanoma progression.

Figure 2

(A) Tumor volume (P<0.05. PBS: n = 17, 2.17-mAlb: n = 23). (B) Tumor weight (PBS: n = 17, 2.17-mAlb: n = 23. * P<0.05). (C) 2.17-mAlb inhibited B16 melanoma growth in vitro when cultured with mouse serum (n = 4. * P<0.05). Data are means±SD.